Atara Biotherapeutics, Inc. financial data

Symbol
ATRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2380 Conejo Spectrum St, Suite 200, Thousand Oaks, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 57.8 % -78.6%
Quick Ratio 9.33 % +31.2%
Debt-to-equity -248 % -138%
Return On Equity 134 %
Return On Assets -90.2 % +13.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.76M shares -94.3%
Common Stock, Shares, Outstanding 5.74M shares -94.4%
Entity Public Float 162M USD -77.4%
Common Stock, Value, Issued 1K USD -90%
Weighted Average Number of Shares Outstanding, Basic 7.47M shares +75.4%
Weighted Average Number of Shares Outstanding, Diluted 7.47M shares +75.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 172M USD -27.5%
General and Administrative Expense 41.9M USD -20.5%
Costs and Expenses 232M USD -13.7%
Operating Income (Loss) -131M USD +55%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -133M USD +54.1%
Income Tax Expense (Benefit) 18K USD +200%
Net Income (Loss) Attributable to Parent -133M USD +54.1%
Earnings Per Share, Basic 25.2 USD/shares +82.1%
Earnings Per Share, Diluted 25.2 USD/shares +82.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46.5M USD -28.3%
Accounts Receivable, after Allowance for Credit Loss, Current 1.34M USD +719%
Inventory, Net 14M USD +112%
Other Assets, Current 9.21M USD -1.95%
Assets, Current 91.9M USD -22.6%
Property, Plant and Equipment, Net 1.66M USD -64.1%
Operating Lease, Right-of-Use Asset 45.8M USD -22.5%
Other Assets, Noncurrent 3.36M USD -46.6%
Assets 143M USD -24.4%
Accounts Payable, Current 2.15M USD -67%
Employee-related Liabilities, Current 7.77M USD -46.2%
Accrued Liabilities, Current 8.06M USD -2.89%
Contract with Customer, Liability, Current 77.8M USD
Liabilities, Current 156M USD +97.2%
Contract with Customer, Liability, Noncurrent 470K USD -99.4%
Operating Lease, Liability, Noncurrent 35.2M USD -27.3%
Other Liabilities, Noncurrent 3.97M USD -18.1%
Liabilities 233M USD -2.66%
Accumulated Other Comprehensive Income (Loss), Net of Tax 22K USD
Retained Earnings (Accumulated Deficit) -2.04B USD -6.98%
Stockholders' Equity Attributable to Parent -90.5M USD -78.1%
Liabilities and Equity 143M USD -24.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.6M USD +22.9%
Net Cash Provided by (Used in) Financing Activities 24.1M USD +10173%
Net Cash Provided by (Used in) Investing Activities 14.7M USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 5.74M shares -94.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 46.6M USD -28.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 114K USD +1.79%
Deferred Tax Assets, Valuation Allowance 475M USD +12.4%
Deferred Tax Assets, Gross 487M USD +11.2%
Operating Lease, Liability 57M USD -19.6%
Depreciation 3.2M USD -5.88%
Payments to Acquire Property, Plant, and Equipment 127K USD -68.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -133M USD +53.9%
Lessee, Operating Lease, Liability, to be Paid 74.5M USD -19.9%
Property, Plant and Equipment, Gross 19.7M USD +0.48%
Operating Lease, Liability, Current 13.7M USD +10%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.5M USD +2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 17.2M USD -10.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +20.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 17.5M USD -20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.3M USD -3.41%
Deferred Tax Assets, Operating Loss Carryforwards 324M USD +6.94%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 160M USD +6.21%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.76M USD -65.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 11.6M USD -23.7%
Share-based Payment Arrangement, Expense 31.1M USD -33.6%
Interest Expense 4.77M USD +13%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares